AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
At close: Sep 3, 2026
AccuStem Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.01 | 0.01 | 0.01 | 0.02 | 0.73 | - |
Cash & Short-Term Investments | 0.01 | 0.01 | 0.01 | 0.02 | 0.73 | - |
Cash Growth | -58.75% | 176.04% | -76.51% | -97.07% | - | - |
Other Receivables | - | - | - | - | - | 1.35 |
Receivables | - | - | - | - | - | 1.35 |
Prepaid Expenses | 0.09 | 0.04 | 0.05 | 0.11 | 0.17 | - |
Other Current Assets | - | - | - | - | 0.03 | - |
Total Current Assets | 0.11 | 0.05 | 0.05 | 0.13 | 0.93 | 1.35 |
Property, Plant & Equipment | - | - | 0 | 0 | 0.01 | - |
Other Long-Term Assets | 1.5 | 1.5 | - | - | - | - |
Total Assets | 1.61 | 1.55 | 0.05 | 0.13 | 0.94 | 1.35 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.62 | 0.7 | 0.8 | 0.58 | 0.31 | 0.39 |
Accrued Expenses | 0.02 | 0.87 | 0.16 | 0.46 | 0.66 | 0.31 |
Short-Term Debt | 0.06 | 0.02 | 0.03 | 0.06 | 0.11 | - |
Other Current Liabilities | 5.02 | 3.35 | 2.37 | 1.15 | - | - |
Total Current Liabilities | 5.72 | 4.95 | 3.36 | 2.25 | 1.08 | 0.7 |
Total Liabilities | 5.72 | 4.95 | 3.36 | 2.25 | 1.08 | 0.7 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 6.39 | 6.37 | 4.7 | 4.4 | 4.32 | 1.5 |
Retained Earnings | -10.52 | -9.78 | -8.03 | -6.52 | -4.47 | -0.72 |
Comprehensive Income & Other | - | - | - | - | - | -0.14 |
Shareholders' Equity | -4.12 | -3.4 | -3.31 | -2.11 | -0.14 | 0.65 |
Total Liabilities & Equity | 1.61 | 1.55 | 0.05 | 0.13 | 0.94 | 1.35 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.06 | 0.02 | 0.03 | 0.06 | 0.11 | - |
Net Cash (Debt) | -0.05 | -0.01 | -0.02 | -0.03 | 0.63 | - |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.06 | - |
Filing Date Shares Outstanding | 16.07 | 16.07 | 12.1 | 11.35 | 11.35 | 10 |
Total Common Shares Outstanding | 16.07 | 16.07 | 12.1 | 11.35 | 11.35 | 10 |
Working Capital | -5.62 | -4.9 | -3.31 | -2.12 | -0.15 | 0.65 |
Book Value Per Share | -0.26 | -0.21 | -0.27 | -0.19 | -0.01 | 0.07 |
Tangible Book Value | -4.12 | -3.4 | -3.31 | -2.11 | -0.14 | 0.65 |
Tangible Book Value Per Share | -0.26 | -0.21 | -0.27 | -0.19 | -0.01 | 0.07 |
Machinery | - | 0.01 | 0.01 | 0.01 | 0.01 | - |